Javascript must be enabled to continue!
An Observational Study to Assess Venous Thromboembolism (VTE) Prophylaxis Compliance and Patient Risk Stratification in a Tertiary Care Hospital
View through CrossRef
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant yet largely preventable cause of morbidity and mortality among hospitalized patients. Despite the availability of evidence-based guidelines from organizations such as the American College of Chest Physicians (ACCP) and the National Institute for Health and Care Excellence (NICE), adherence to recommended prophylactic measures remains inconsistent in many healthcare settings. The present study aimed to assess the level of compliance with VTE prophylaxis guidelines and to examine patient risk stratification in a tertiary care hospital. A retrospective observational cross-sectional study was conducted among hospitalized patients in selected wards of a tertiary care center. Data were collected using a structured case report form and a validated questionnaire through review of electronic health records and consultation with healthcare professionals. A total of 96 patients with documented VTE risk assessments were included for clinical analysis, while 100 survey responses were analyzed for statistical evaluation. Patients were categorized into low-, moderate-, and high-risk groups based on standard risk assessment models. Statistical analysis was performed using IBM SPSS Statistics version 26, employing descriptive statistics, Pearson correlation analysis, chi-square tests, and regression analysis to examine relationships among clinical variables and prophylaxis practices. The findings revealed moderate but inconsistent adherence to VTE prophylaxis guidelines. Among the studied patients, 48% were categorized as high risk, 35% as moderate risk, and 17% as low risk for VTE. Appropriate prophylaxis was administered to 58% of high-risk patients, indicating that 42% remained untreated despite their elevated risk. In the moderate-risk group, 42% received prophylaxis, reflecting partial compliance with guidelines. Conversely, 18% of low-risk patients received unnecessary prophylaxis, suggesting overtreatment. Pharmacological prophylaxis, particularly low-molecular-weight heparin and unfractionated heparin, was commonly used, although mechanical methods were also applied. Dose adherence was inconsistent, with 56% of patients missing at least one prophylactic dose, and only 28% receiving regular monitoring for potential bleeding complications. Correlation analysis indicated weak associations between risk assessment and prophylaxis prescription, whereas discussions of clinical guidelines among healthcare providers demonstrated a modest positive relationship with dose adherence.
Publication and Advance Research Welfare Society
Title: An Observational Study to Assess Venous Thromboembolism (VTE) Prophylaxis Compliance and Patient Risk Stratification in a Tertiary Care Hospital
Description:
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant yet largely preventable cause of morbidity and mortality among hospitalized patients.
Despite the availability of evidence-based guidelines from organizations such as the American College of Chest Physicians (ACCP) and the National Institute for Health and Care Excellence (NICE), adherence to recommended prophylactic measures remains inconsistent in many healthcare settings.
The present study aimed to assess the level of compliance with VTE prophylaxis guidelines and to examine patient risk stratification in a tertiary care hospital.
A retrospective observational cross-sectional study was conducted among hospitalized patients in selected wards of a tertiary care center.
Data were collected using a structured case report form and a validated questionnaire through review of electronic health records and consultation with healthcare professionals.
A total of 96 patients with documented VTE risk assessments were included for clinical analysis, while 100 survey responses were analyzed for statistical evaluation.
Patients were categorized into low-, moderate-, and high-risk groups based on standard risk assessment models.
Statistical analysis was performed using IBM SPSS Statistics version 26, employing descriptive statistics, Pearson correlation analysis, chi-square tests, and regression analysis to examine relationships among clinical variables and prophylaxis practices.
The findings revealed moderate but inconsistent adherence to VTE prophylaxis guidelines.
Among the studied patients, 48% were categorized as high risk, 35% as moderate risk, and 17% as low risk for VTE.
Appropriate prophylaxis was administered to 58% of high-risk patients, indicating that 42% remained untreated despite their elevated risk.
In the moderate-risk group, 42% received prophylaxis, reflecting partial compliance with guidelines.
Conversely, 18% of low-risk patients received unnecessary prophylaxis, suggesting overtreatment.
Pharmacological prophylaxis, particularly low-molecular-weight heparin and unfractionated heparin, was commonly used, although mechanical methods were also applied.
Dose adherence was inconsistent, with 56% of patients missing at least one prophylactic dose, and only 28% receiving regular monitoring for potential bleeding complications.
Correlation analysis indicated weak associations between risk assessment and prophylaxis prescription, whereas discussions of clinical guidelines among healthcare providers demonstrated a modest positive relationship with dose adherence.
Related Results
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
<p dir="ltr">Individuals with rheumatoid arthritis (RA) are at around 50-100% increased risk of venous thromboembolism (VTE). In 2019, signals emerged suggesting an increased...
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
Cardiovascular comorbidity in rheumatoid arthritis : studies on venous thromboembolism
<p dir="ltr">Individuals with rheumatoid arthritis (RA) are at around 50-100% increased risk of venous thromboembolism (VTE). In 2019, signals emerged suggesting an increased...
Outcomes of Venous Thromboembolism in Hospitalized Non-Hodgkin Lymphoma Patients: Analysis from the Nationwide Inpatient Sample Database
Outcomes of Venous Thromboembolism in Hospitalized Non-Hodgkin Lymphoma Patients: Analysis from the Nationwide Inpatient Sample Database
Abstract
Introduction:
Venous Thromboembolism (VTE), which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is one of the major caus...
Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection
Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection
Background: COVID-19 infection is associated with a high risk of venous thromboembolism (VTE) events. VTE prophylaxis reduces the risk of these events. The optimal dose of VTE prop...
Prevalence and Mortality Predictors of Venous Thromboembolism Among 48 Model Hospital Patients (2016-2020)
Prevalence and Mortality Predictors of Venous Thromboembolism Among 48 Model Hospital Patients (2016-2020)
Background: Venous thromboembolism (VTE) is the third most prevalent vascular disease, and it has a substantial impact on morbidity and mortality. Although its effectiveness, evide...
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Study object: Describe the direct treatment costs due to venous thromboembolism complications 90 days after surgery by using national health insurance reimbursement database. Patie...
Predictive Efficacy of the Khorana Score in Black Patients: Retrospective Cohort Study
Predictive Efficacy of the Khorana Score in Black Patients: Retrospective Cohort Study
Background
The Khorana score(KS) is a predictive score used to determine the risk of venous thromboembolism (VTE) in cancer(CA) patients(pts). According to the origi...

